Jane Eagleson
Corporate Officer/Principal bij Bleecker Street Consulting
Profiel
Jane Eagleson is the owner of Bleecker Street Consulting.
She previously worked as Senior Director-Asian Business Development at Pfizer Inc., Independent Director at Zomedica Corp., Head-Growth Strategies at Argenta Ltd., Vice President-Clinical & Regulatory Affairs at Nexvet Australia Pty Ltd., and Vice President of Clinical & Regulatory Affairs at Nexvet US, Inc. She received an undergraduate degree from The University of Sydney and a graduate degree from Massey University.
Actieve functies van Jane Eagleson
| Bedrijven | Functie | Begin |
|---|---|---|
Bleecker Street Consulting
 Bleecker Street Consulting Agricultural Commodities/MillingProcess Industries Bleecker Street Consulting provides advice and assistance in the selection, development, and registration of animal health pharmaceutical products. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Eerdere bekende functies van Jane Eagleson
| Bedrijven | Functie | Einde |
|---|---|---|
Argenta Ltd.
 Argenta Ltd. BiotechnologyHealth Technology Argenta Ltd. operates as a pharmaceutical contract manufacturing company. It serves animal health research, veterinary, and GMP manufacting. The company was founded by Douglas Robert Cleverly in 2006 and is headquartered in Manurewa, New Zealand. | Corporate Officer/Principal | - |
Nexvet US, Inc.
 Nexvet US, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Zoetis, Inc., Nexvet US, Inc. engages in biological research. The company is based in San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Algemeen Adviseur | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
| ZOMEDICA CORP. | Directeur/Bestuurslid | - |
Opleiding van Jane Eagleson
| Massey University | Graduate Degree |
| The University of Sydney | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ZOMEDICA CORP. | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Bleecker Street Consulting
Bleecker Street Consulting Agricultural Commodities/MillingProcess Industries Bleecker Street Consulting provides advice and assistance in the selection, development, and registration of animal health pharmaceutical products. The private company is based in New York, NY. | Process Industries |
Nexvet US, Inc.
Nexvet US, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Zoetis, Inc., Nexvet US, Inc. engages in biological research. The company is based in San Francisco, CA. | Commercial Services |
Argenta Ltd.
Argenta Ltd. BiotechnologyHealth Technology Argenta Ltd. operates as a pharmaceutical contract manufacturing company. It serves animal health research, veterinary, and GMP manufacting. The company was founded by Douglas Robert Cleverly in 2006 and is headquartered in Manurewa, New Zealand. | Health Technology |
